Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Letter |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82060 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Mahidol University |
| id |
th-mahidol.82060 |
|---|---|
| record_format |
dspace |
| spelling |
th-mahidol.820602023-05-19T14:49:46Z Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study Seree-aphinan C. Mahidol University Medicine 2023-05-19T07:49:46Z 2023-05-19T07:49:46Z 2023-05-01 Letter Journal of the European Academy of Dermatology and Venereology Vol.37 No.5 (2023) , e572-e575 10.1111/jdv.18890 14683083 09269959 36662625 2-s2.0-85147389245 https://repository.li.mahidol.ac.th/handle/123456789/82060 SCOPUS |
| institution |
Mahidol University |
| building |
Mahidol University Library |
| continent |
Asia |
| country |
Thailand Thailand |
| content_provider |
Mahidol University Library |
| collection |
Mahidol University Institutional Repository |
| topic |
Medicine |
| spellingShingle |
Medicine Seree-aphinan C. Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study |
| author2 |
Mahidol University |
| author_facet |
Mahidol University Seree-aphinan C. |
| format |
Letter |
| author |
Seree-aphinan C. |
| author_sort |
Seree-aphinan C. |
| title |
Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study |
| title_short |
Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study |
| title_full |
Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study |
| title_fullStr |
Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study |
| title_full_unstemmed |
Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study |
| title_sort |
risk–benefit profiles associated with receiving moderna covid-19 (mrna-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low sars-cov-2-specific immunity following the primary series: a prospective cohort study |
| publishDate |
2023 |
| url |
https://repository.li.mahidol.ac.th/handle/123456789/82060 |
| _version_ |
1781413965491863552 |